Zuellig Pharma Korea blasted for unfair contract terms

Published: 2007-06-11 06:59:00

Updated: 2007-06-11 06:59:00

The unfair contract terms between Zuellig Pharma Korea (ZPK) and associate wholesalers, including ZPK's dubious third-party logistic patterns, have reignited criticism from the overall wholesaling industry.

Market experts pointed out that ZPK has been blamed for hurting the benefits of its ass...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK